<DOC>
	<DOCNO>NCT01666080</DOCNO>
	<brief_summary>This treatment guideline second great allogeneic hematopoietic stem cell transplant ( HSCT ) use reduce intensity conditioning ( RIC ) patient non-malignant malignant disease . This regimen , consist busulfan , fludarabine , low dose total body irradiation ( TBI ) , design promote engraftment patient fail achieve acceptable level donor-derived engraftment follow previous allogeneic HCT .</brief_summary>
	<brief_title>Second Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning ( RIC )</brief_title>
	<detailed_description>There research element except collection routine clinical data . Patients consent allow routine clinical data collect maintain OnCore , Masonic Cancer Center 's ( MCC ) clinical database , specific transplant related endpoint University Of Minnesota Blood Bone Marrow Database part historical database maintain department .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Diagnosis disease second great hematopoietic stem cell transplant need due insufficient donor chimerism follow hematopoietic recovery previous HSCT . Determination `` insufficiency donor chimerism '' make treat transplant physician . Occasionally donor derive engraftment may present , sustain aplasia fail recovery sufficient hematopoiesis require administration second graft . This intervention may use situation . Donor Availability : Patients consider transplantation must sufficient graft base current criterion University Minnesota Blood Marrow Transplantation Program Transplantation use sufficiently match related donor ( matched sibling ) unrelated donor consider . Both granulocytecolony stimulating factor ( GCSF ) stimulate peripheral blood graft bone marrow graft consider , although bone marrow priority . Cord blood graft , relate unrelated , also eligible . As protocol use reduce intensity regimen , protocol use current recommendation University Minnesota choose cord blood graft . If single cord blood unit cell dose insufficient , double cord transplantation consider sufficiently match cord blood unit available . The priority choose cord blood donor base current institutional recommendation . Exclusion Metabolic Disorder Inherited Disorder Carrier Status relate donor unrelated cord blood graft appropriate primary disease . At discretion treat transplant physician , allograft previous donor may use , available . Age , Performance Status , Consent Age : 0 55 year Consent : voluntary write consent ( adult parental/guardian ) Previous irradiation precludes safe administration additional dose 200 cGy total body irradiation ( TBI ) . Radiation Oncology evaluate patient previous radiation therapy TBI approval receive additional 200 cGy TBI Pregnant breastfeed Active , uncontrolled infection infection stable improve 1 week appropriate therapy ( 4 week presume documented fungal infection ) permit HIV positive While would advantageous begin therapy second transplant regimen &gt; 6 month follow prior myeloablative regimen &gt; 2 month reduce intensity regimen , recognize circumstance may practical .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>second stem cell transplant</keyword>
	<keyword>donor hematopoietic engraftment</keyword>
	<keyword>hematopoietic stem cell transplantation</keyword>
	<keyword>inherit metabolic disorder</keyword>
</DOC>